Loading…
← CockpitCompetitor Analysis › 600866.SS Star Lake Bioscience Co., Inc. Class AOpen in the cockpit ↗

Star Lake Bioscience Co., Inc. Class A600866.SSCompetitor analysis, valuation and peers

China · CNY·Consumer Staples›Food: Specialty/Candy

Guangdong biochemical company producing MSG, nucleotides and other fermentation-based food additives and fine chemicals.

≈ A smaller Chinese fermentation/food-additive producerMomentum leader 82
Mkt cap
$1.07B
US dollars, full cap
Free float
55%
of shares outstanding
$/day
$12.7M
20-day average traded
Fwd P/E
37.4×
forward earnings
ROIC−WACC
-1.2 pp
WACC 5.0%
Hurdle
n/a
no reverse DCF
Next earnings
160 days
27 Apr 2027
Close · CNYCN¥4.34
1D+0.5%
1W+4.1%
1M+5.6%
3M-0.7%
6M-24.0%
YTD-37.5%
1Y-39.1%
ATR %2.5%
52w lowhigh47.5% off high

What Star Lake Bioscience does

Guangdong biochemical company producing MSG, nucleotides and other fermentation-based food additives and fine chemicals.

In one line: A smaller Chinese fermentation/food-additive producer.

Products and services

  • MSG
  • Nucleotides (flavor enhancers)
  • Amino acids/fine chemicals

Customers

  • Food manufacturers
  • Foodservice/flavor industry

Where it sits in the supply chain

  • Specialty chemicals
  • Food additives
  • MSG, nucleotides, amino acids

What could go right

  • Food-additive demand growth

What could go wrong

  • Commodity pricing pressure
  • Fermentation feedstock cost swings

Moat: none. Commodity fermentation-chemical producer without differentiated pricing power.

Headquarters: Zhaoqing, Guangdong, China · Employees: 10,528

Named competitors

Star Lake Bioscience at a glance

Size Star Lake Bioscience (600866.SS) is a China Consumer Staples company (Food: Specialty/Candy) with a market value of $1.07B, the 2028th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥4.34 on 18 Nov 2026.

Performance Over six months the shares fell 24.0%, against -12.6% for the median peer and -20.0% for the China market (cap-weighted) — 7th lowest of 20 in its peer set.

Growth Revenue fell 3.0% over the last twelve months (peer median +8.5%); the operating margin is 0.4% (peer median 7.2%).

Valuation It trades at 37.4× forward earnings against a peer median of 18.6× (4th most expensive of 18).

Capital Return on invested capital runs 1.2 points below its cost of capital (5.0% WACC).

Next results Next results expected around 27 Apr 2027 (exchange calendar; dates can move).

Relative performance

70809010021 May 202621 Aug 202618 Nov 2026Peer median 88600866.SS 78
Six months, rebased to 100: Star Lake Bioscience against the median of its 20 peers (local-currency closes).

Star Lake Bioscience financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥16.1BCN¥15.9BCN¥17.3BCN¥17.4BCN¥17.5B
Revenue growth—-8%0%0%—
Gross profitCN¥2.04BCN¥2.44BCN¥2.79BCN¥2.26BCN¥2.87B
EBITDAn/aCN¥2.02BCN¥2.42BCN¥2.02BCN¥2.71B
Net incomeCN¥19.7MCN¥979MCN¥943MCN¥678MCN¥608M
Free cash flow-CN¥2.33B-CN¥730MCN¥1.76BCN¥1.66BCN¥1.21B
Capital expenditureCN¥1.96BCN¥2.04BCN¥638MCN¥376MCN¥452M
Total debtCN¥7.98BCN¥6.36BCN¥4.15BCN¥4.40BCN¥5.04B

Quarterly statements and history in the cockpit →

Star Lake Bioscience competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%+40%-10%0%+10%2815FLO001800600929002650ITMSENEA00499005462803602602002891605016MANORAMA03364958300138BIKAJI600866.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Star Lake Bioscience is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%20×40×60×2815FLO600929ITMSENEA0049900546280360002891605016MANORAMA0336002956300138BIKAJI600866.SSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Star Lake Bioscience is the large dot.

Star Lake Bioscience competitors and peer comparison

Head to head with its named competitors (600866.SS vs 600873.SS vs 0546.HK vs 600186.SS)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Star Lake Bioscience 600866.SS$1.07B-24%-3%0%37.4×n/a
MeiHua 600873.SS$2.86B-23%-3%4%16.0×n/a
Fufeng 0546.HK$1.24B-36%+1%4%7.0×n/a
Lotus 600186.SS$2.47B-13%+21%13%39.1×n/a

How Star Lake Bioscience compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Star Lake Bioscience against its 20 peers (data as of 18 Nov 2026)
Measure600866.SSPeer medianRank in peer set
1-month return+5.6%+0.3%2nd highest of 21
6-month return-24.0%-12.6%7th lowest of 20
Distance from 52-week high-47.5%-26.9%4th lowest of 21
Revenue growth (TTM)-3.0%+8.5%4th lowest of 21
Operating margin0.4%7.2%2nd lowest of 21
Forward P/E37.4×18.6×4th most expensive of 18
ROIC minus cost of capital-1.2 pp+1.0 pp8th lowest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Star Lake Bioscience 600866.SSChina$1.07B-24%-3%0%37.4×n/an/a
ARIAKE JAPAN 2815.TJapan$1.06B-4%+5%17%17.6×-6.1%+6.1%
Flowers Foods FLOUnited States$1.11B-27%+1%6%8.2×-6.6%+3.7%
ORION 001800.KSSouth Korea$1.02B-7%+16%15%n/a-15.9%+8.3%
Snowsky Salt Industry 600929.SSChina$1.14B-31%+32%1%51.8×n/an/a
Jiangxi Qiyunshan Food 2797.HKHong Kong$1.00Bn/a-7%17%n/an/an/a
Jiajia Food 002650.SZChina$981M-27%-9%-10%n/a3.8%-10.0%
Italmobiliare ITM.MIItaly$1.17B-13%+8%14%14.0×n/an/a
Seneca Foods SENEAUnited States$1.18B+23%+12%8%11.8×-10.4%+2.5%
Lotte 004990.KSSouth Korea$1.21B-23%0%1%70.0×n/an/a
Fufeng 0546.HKHong Kong$1.24B-36%+1%4%7.0×n/an/a
Lotte Wellfood 280360.KSSouth Korea$921M+15%+5%4%10.1×-1.8%+15.2%
Nisshin OilliO 2602.TJapan$1.25B+19%+9%4%18.6×n/an/a
Yantai China Pet Foods 002891.SZChina$1.25B-17%+21%4%29.4×n/an/a
Shandong Bailong Chuangyuan Bio-Tech 605016.SSChina$1.25B-26%+19%32%19.1×9.1%+22.5%
Manorama Industries MANORAMA.NSIndia$1.26B+36%+60%24%36.1×32.6%+46.9%
Huabao International 0336.HKHong Kong$1.27B-13%+13%3%23.8×14.6%-2.7%
T. Hasegawa 4958.TJapan$900M+14%+8%12%18.5×n/an/a
Guilin Seamild Foods 002956.SZChina$900M-11%+21%11%22.1×8.2%+17.0%
Chenguang Biotech 300138.SZChina$896M+9%-4%6%15.4×-1.6%+10.9%
Bikaji Foods International BIKAJI.NSIndia$1.28B-29%+13%9%42.4×39.9%+17.5%

Questions

Who are Star Lake Bioscience's main competitors?
Named competitors: MeiHua Holdings (600873.SS), Fufeng Group (0546.HK), Lotus Holdings (600186.SS). The cockpit's measured peer set (industry) also includes ARIAKE JAPAN (2815.T), Flowers Foods (FLO), ORION (001800.KS), Snowsky Salt Industry (600929.SS), Jiangxi Qiyunshan Food (2797.HK), Jiajia Food (002650.SZ).
Is Star Lake Bioscience expensive compared with its peers?
On forward p/e it trades at 37.4× against a peer median of 18.6×, 4th most expensive of 18 in its peer set.
How has Star Lake Bioscience stock performed?
Over six months to 18 Nov 2026 the shares returned -24.0% against -12.6% for the median peer; over one year -39.1%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.